Jan Balvan
Papers
1
Total Citations
38
H-Index
1
About
Jan Balvan is a pioneering researcher at the intersection of nanomedicine and oncology, with a primary focus on developing advanced microrobotic platforms for targeted cancer therapy. His most notable contribution is the design and validation of magnetically driven, self-degrading zinc-containing cystine microrobots for the treatment of prostate cancer, a breakthrough published in 2023 that has already garnered 38 citations. This work addresses a critical challenge in oncology by combining wireless magnetic guidance with biodegradable materials, enabling precise drug delivery while minimizing long-term toxicity. Balvan’s research integrates materials science, magnetic actuation, and tumor biology to create intelligent therapeutic systems that degrade safely after treatment. His innovative approach has positioned him as a rising leader in the field of medical microrobots, with his work frequently cited for its potential to revolutionize prostate cancer therapy. Balvan’s achievements highlight his commitment to translating cutting-edge nanotechnology into practical, patient-centered solutions, making him a key figure to watch in the evolving landscape of targeted cancer nanomedicine.
Research Focus
Key Achievements
Top Papers
- 1